CLINICAL_TRIALS ClinicalTrials.gov record update

Cerebral Spinal Fluid Circulating Tumor DNA (ctDNA) Analysis in Patients With Aggressive B-cell Lymphoma Receiving Front Line Therapy and at High Risk for Central Nervous System Relapse

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06736613
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:28:47.318301+00:00
Published At: 2025-12-18T00:00:00+00:00
Record Updated At: 2025-12-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Diffuse Large B Cell Lymphoma", "High-grade B-cell Lymphoma", "Stage III High Grade B-Cell Lymphoma", "Stage IV High Grade B-Cell Lymphoma", "DLBCL - Diffuse Large B Cell Lymphoma", "Intravascular Large B-Cell Lymphoma", "Diffuse Large B Cell Lymphoma of Breast", "Diffuse Large B Cell Lymphoma of Testis", "HIV-associated Diffuse Large B Cell Lymphoma", "Double Expressor DLBCL"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-12-18"
protocolSection.identificationModule.nctId: "NCT06736613"
protocolSection.identificationModule.officialTitle: "Cerebral Spinal Fluid Circulating Tumor DNA (ctDNA) Analysis in Patients With Aggressive B-cell Lymphoma Receiving Front Line Therapy and at High Risk for Central Nervous System Relapse"
protocolSection.statusModule.overallStatus: "RECRUITING"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.